BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27998760)

  • 1. Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27
    Hu B; Hua L; Ni W; Wu M; Yan D; Chen Y; Lu C; Chen B; Wan C
    Cancer Lett; 2017 Mar; 388():220-229. PubMed ID: 27998760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
    Hua L; Hu B; Yan D; Liu J; Shen Y; Zhao F; Shen C; Chen B; Cui X
    Pathol Res Pract; 2017 Jun; 213(6):688-697. PubMed ID: 28476378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CACYBP Enhances Cytoplasmic Retention of P27
    Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
    Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
    Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.
    Yuan F; Cheng Q; Li G; Tong T
    PLoS One; 2015; 10(10):e0141678. PubMed ID: 26517370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.
    Wan C; Hou S; Ni R; Lv L; Ding Z; Huang X; Hang Q; He S; Wang Y; Cheng C; Gu XX; Xu G; Shen A
    Oncogene; 2015 Jan; 34(2):237-45. PubMed ID: 24336329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
    Shehata MA; Nosseir HR; Nagy HM; Farouk G
    Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.
    Lee EK; Kim DG; Kim JS; Yoon Y
    Cancer Res; 2011 Nov; 71(21):6827-35. PubMed ID: 21917729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.
    Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
    Matsuda Y
    World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR.
    Liu B; Yang G; Wang X; Liu J; Lu Z; Wang Q; Xu B; Liu Z; Li J
    J Cell Physiol; 2020 Oct; 235(10):6929-6941. PubMed ID: 32003018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress.
    Wang J; McGrail DJ; Bhupal PK; Zhang W; Lin KY; Ku YH; Lin T; Wu H; Tsai KC; Li K; Peng CY; Finegold MJ; Lin SY; Tsai RYL
    Mol Cancer Res; 2020 May; 18(5):723-734. PubMed ID: 32051231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
    Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
    Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
    Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
    Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.